Biotin
It is an essential cofactor for several carboxylase enzymes, which are involved in the metabolism of fats, proteins, and carbohydrates.
Biotin deficiency can lead to a range of symptoms, including skin rashes, hair loss, and neurological impairments.
Biotin supplements are commonly used to support healthy hair, skin, and nails, as well as to aid in the management of certain medical conditions, such as diabetes and certain types of metabolic disorders.
Researchers can utilize the PubCompare.ai platform to optimize their biotin research by accessing reliable protocols from literature, preprints, and patents, and leveraging advanced AI comparisons to identify the best products and procedures, enhancing research reproducibiltiy and accuarcy.
Most cited protocols related to «Biotin»
Trimming adapters from Nextera LMP reads is like a reverse process of Nextera LMP library construction. To process Nextera mate-pair reads, the program first trims the adapters as if it is dealing with PE reads. Then, it trims junction adapters from the processed paired reads separately using the extended version of Algorithm 1.
The CLIP-Seq analysis has been performed using an in-house developed pipeline. Regions formed by at least five overlapping reads were included to the analysis. For PAR-CLIP data, peaks containing adequate T-to-C (sense strand) or A-to-G (antisense strand) incorporation were selected. At least two transitions in the same position for peaks with less than 50 reads were required, while for the remaining regions we applied the threshold of >5%, as indicated by Hafner et al. (11 (link)). For all CLIP-Seq data sets having replicates, a peak had to be present in at least two replicates in order to be considered as valid. Where available, top expressed miRNAs were retrieved from the original publication. In all other instances, we analyzed publically available small-RNA-Seq libraries derived from the relevant cell lines. miRNA:gene interactions were inferred using a CLIP-peak-guided MRE search algorithm considering the miRNA:mRNA binding type, binding free energy, MRE conservation and AU flanking content.
Changes over 50% were utilized as a threshold for microarray and biotin pull-down experiments. In cases where replicates were available, an interaction had to be present in at least two replicates, in order to be included to the database.
Most recents protocols related to «Biotin»
Example 2
100 mg of the Sarcodon aspratus extracts according to the present invention;
an appropriate amount of a vitamin mixture;
70 μg of vitamin A acetate;
1.0 mg of vitamin E;
0.13 mg of vitamin B1;
0.15 mg of vitamin B2;
0.5 mg of vitamin B6;
0.2 μg of vitamin B12;
10 mg of vitamin C;
10 μg of biotin;
1.7 mg of nicotinic acid amide;
50 μg of folate;
0.5 mg of calcium pantothenate;
an appropriate amount of a mineral mixture;
1.75 mg of ferrous sulfide;
0.82 mg of zinc oxide;
25.3 mg of magnesium carbonate;
15 mg of potassium phosphate monobasic;
55 mg of dicalcium phosphate;
90 mg of potassium citrate;
100 mg of calcium carbonate; and
24.8 mg of magnesium chloride.
The composition ratio of the vitamins and the mineral mixture described above may be determined according to a composition ratio used in general functional health foods, and the combination ratio of the vitamins and the mineral mixture may be arbitrarily determined. According to a conventional method of preparing functional health foods, these components are mixed, granules are prepared, and the granules are used to prepare a composition for a functional health food.
Example 5
In patients with congestive heart failure, introducing number(s)/factor(s) generated based on the heart rate variability into a treatment regimen, such as the ratio between two consecutive heartbeat variabilities, may improve the response to diuretic therapy. If the patient already experienced loss of the heart rate variability, introducing the change in therapy can be followed by monitoring the effect of treatment on reversal of this loss. A use of previous electrocardiogram strips from the subject may enable to generate a “healthier-pattern of variability”. Based on the patient's variability pattern the app determines a dynamic individualized irregularity pattern for a dosing regimen.
EXAMPLE 21
In order to determine PD-1 competition efficiency of B7-H1 binding Nanobodies, the positive clones of the binding assay were tested in an ELISA competition assay setup.
In short, 2 μg/ml B7-H1 ectodomain (rhB7H1-Fc, R&D Systems, Minneapolis, US, Cat #156-B7) was immobilized on maxisorp microtiter plates (Nunc, Wiesbaden, Germany) and free binding sites were blocked using 4% Marvel in PBS. Next, 0.5 μg/ml of PD-1-biotin was preincubated with 10 μl of periplasmic extract containing Nanobody of the different clones and a control with only PD-1-biotin (high control). The PD-1-biotin was allowed to bind to the immobilized ligand with or without Nanobody. After incubation and a wash step, PD-1 binding was revealed using a HRP-conjugated streptavidine. Binding specificity was determined based on OD values compared to controls having received no Nanobody (high control). OD values for the different Nanobody clones are depicted in
EXAMPLE 16
In order to determine competition efficiency of PD-1 binding Nanobodies, the positive clones of the previous binding assay were tested in an ELISA competition assay setup.
In short, 2 μg/ml PD-1 ectodomain (R&D Systems Cat #1086-PD, Minneapolis, US) was immobilized on maxisorp microtiter plates (Nunc, Wiesbaden, Germany) and free binding sites were blocked using 4% Marvel in PBS. Next, 0.5 μg/ml of biotinylated PD-L2 or B7-H1 was preincubated with a dilution series of purified Nanobody. An irrelevant Nanobody against FcgR1 (49C5) was used as a negative controle, since this Nanobody does not bind to PD-1. PD-L2 or B7-H1 without biotin (cold PD-L2 or cold B7-H1) was used as a positive controle for competition. The results are shown in
EXAMPLE 28
In order to determine competition efficiency of PD-L2 binding Nanobodies, the positive clones of the previous binding assay were tested in an ELISA competition assay setup.
In short, 2 μg/ml PD-L2 ectodomain (R&D Systems, Minneapolis, US, Cat #1224-PL) was immobilized on maxisorp microtiter plates (Nunc, Wiesbaden, Germany) and free binding sites were blocked using 4% Marvel in PBS. Next, 0.5 μg/ml of PD-1 was preincubated with a dilution series of purified Nanobody. An irrelevant Nanobody against FcgR1 (49C5) was used as a negative controle, since this Nanobody does not bind to PD-L2. PD-1 without biotin (cold PD-1) was used as a positive controle for competition of PD-1-biotin. The results are shown in
Top products related to «Biotin»
More about "Biotin"
As a water-soluble vitamin, biotin is involved in the metabolism of fats, proteins, and carbohydrates, serving as an essential cofactor for several carboxylase enzymes.
Biotin deficiency can lead to a range of adverse health effects, including skin rashes, hair loss, and neurological impairments.
Consequently, biotin supplements are commonly used to support the health of hair, skin, and nails, as well as to aid in the management of certain medical conditions, such as diabetes and certain types of metabolic disorders.
Researchers can leverage the power of the PubCompare.ai platform to optimize their biotin research.
This innovative AI-driven platform allows researchers to access reliable protocols from literature, preprints, and patents, while utilizing advanced AI comparisons to identify the best products and procedures.
By doing so, researchers can enhance the reproducibility and accuracy of their biotin-related studies.
In addition to the PubCompare.ai platform, researchers may also find value in utilizing tools and reagents such as the LightShift Chemiluminescent EMSA Kit, RNeasy Mini Kit, Biotin RNA Labeling Mix, Vectastain Elite ABC kit, Bovine serum albumin, Vectastain ABC kit, Streptavidin agarose beads, Anti-biotin microbeads, and TRIzol reagent.
These resources can provide valuable support for various aspects of biotin-related research, including protein-DNA interactions, RNA extraction and labeling, and affinity-based purification.
By combining the insights gained from the MeSH term description, the Metadescription, and the utilization of relevant tools and reagents, researchers can delve deeper into the complex world of biotin and unlock new discoveries that can contribute to advancements in human health and wellness.